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background: Current guidelines on secondary prevention of SCA do not recommend an ICD if VT/VF occurs within 24-48 hrs of a myocardial 
infarction (MI). We retrospectively reviewed the data on a large group of post-MI SCA survivors that were prescribed the wearable cardioverter 
defibrillator (WCD) after hospital discharge. We sought to determine risk of secondary SCA events and 90 day mortality in this group.
methods: The WCD (LifeVest®, ZOLL) medical order registry was screened for patients (pts) coded as having had a “recent MI with EF≤35%” or 
given an ICD9 410.xx diagnostic code (acute MI) who had a concomitant (≤48 hrs) SCA (VF or unconscious VT). These were matched to device-
recorded data and the Social Security Death Master File (SSDMF).
results: Between 11/28/11 and 12/31/12, 447 consecutive patients (aged 58.5 ± 11.5, 76% male) were prescribed the WCD after recent MI 
complicated by SCA and were included in this study. Pts wore the WCD for a median 70 days. Pt average LVEF was 33 ± 12% (29% with LVEF >35%) 
and 89% were revascularized post-MI. The primary SCA event occurred most often at hospital/ambulance (56%), followed by outside the home 
(26%) and home (18%). Five pts (1.1%) received twelve appropriate shocks over six SCA events (all recorded VT/VF within 24 hours were considered 
one event). All shocks converted VT/VF, although one pt died from asystole following a shock. Pts were shocked a median of 39 days (range: 24-100 
days) after starting WCD use. Shocked and non-shocked pts had similar demographics and primary SCA data. The top reasons for ending WCD use 
were LVEF/condition improvement (43%) and ICD implantation (28%). Ninety-day survival was 99%.
conclusions: This study represents one of the largest reviews on this pt population, as these pts are often excluded from trials. Despite having 
a primary VT/VF event with MI, pts in this study had a good prognosis post-hospital discharge with a WCD. Ninety-day survival was high at 99%, 
indicating the WCD is an effective tool for protecting these at-risk patients until recovery may occur or a plan for long-term SCA protection can be 
implemented.
